Investors Pour $3.2 Billion into Biotech Stocks in Record-Breaking Day for Follow-On Offerings

In a significant sign of investor confidence in the biotech sector, a record-setting $3.2 billion in follow-on stock offerings were sold in a single 24-hour period. Eight biotech companies priced new stock sales, with seven increasing their offering sizes to meet high demand, indicating a strong appetite for biotech equities.